Skin treatment device and conductive sheet
By designing a skin treatment device with retractable and flexible conductive sheets and bioadhesive layer, the problem of fixing the application area of the existing beauty mask is solved, and flexible treatment and beauty effects of multiple skin areas are achieved.
Patent Information
- Application Number
- CN202322722726.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Priority Date
- 2023-09-11
- Filing Date
- 2023-10-11
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2033-10-11
AI Technical Summary
The application area of the existing beauty mask is fixed on the cheeks and cannot be treated with other skin areas according to the user's requirements.
A skin treatment device is designed, using a conductive sheet that can retract in any direction and a flexible conductive sheet. Combined with a bioadhesive layer, it can be attached to the user's skin and supplied to the skin through the main body of the device. Current, realize skin treatment in different areas.
The device can effectively treat various skin areas according to the needs of the user, improve the flexibility and effect of skin treatment, and meet the beauty needs of multiple skin areas.
Smart Images

Figure CN222092332U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to a skin treatment device and a conductive sheet. Background Art
[0002] Conventionally, a device has been developed for the purpose of improving the beauty effect on the face (see Patent Document 1 ((Japanese Patent Publication No. 2022-116856))).
[0003] As such a device, Patent Document 1 discloses a beauty mask that is attached to the face of a user and performs a treatment through electrical stimulation.
[0004] This beauty mask includes a mask body and a stimulation body, wherein the mask body covers substantially the entire area of the user's face, and the stimulation body is arranged on the mask body and implements a treatment wave for continuously applying electrical stimulation with a predetermined current intensity to an area corresponding to the user's cheek. Utility Model Content
[0005] Issues to be Solved by Utility Models
[0006] However, the above-mentioned beauty mask has a problem in that the treatment area is designated as the cheek of the user.
[0007] In view of the above situation, the present invention provides a skin treatment device, which can perform skin treatment on skin surfaces of various areas according to the requirements of users.
[0008] Solutions to Solve Problems
[0009] According to one embodiment of the utility model, a skin treatment device is provided. The skin treatment device comprises a conductive sheet at least part of which can be extended and retracted in any direction, or a conductive sheet with flexibility at least part of which can follow the skin surface, and a device body mounted on the conductive sheet and supplying current to the skin surface of the user. The conductive sheet comprises a sheet substrate, a conductive pattern, and a bioadhesive layer. The conductive pattern is arranged on the surface side of one side of the sheet substrate, and comprises a wiring portion and an electrode portion connected to one end side of the wiring portion. The bioadhesive layer is arranged on the side of the conductive pattern opposite to the sheet substrate, and is configured to be adhered to the skin surface of the user.
[0010] According to such an aspect, it is possible to provide a skin treatment device capable of treating skin in various areas according to the user's request. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 It is a top view showing a disassembled state of the skin treatment device of this embodiment.
[0012] Figure 2It means that Figure 1 A top view of the device body after being turned inside out.
[0013] Figure 3 It is a plan view showing a state in which the conductive sheet of the first structural example is disassembled.
[0014] Figure 4 yes Figure 1 AA line section view in.
[0015] Figure 5 This is a block diagram showing the structure of the device body.
[0016] Figure 6 It is a plan view showing a state where a conductive sheet having a bioadhesive layer of another structure is disassembled.
[0017] Figure 7 yes Figure 6 The conductive sheet and Figure 4 The corresponding cross-sectional view.
[0018] Figure 8 It is a top view showing a disassembled state of the skin treatment device including the conductive sheet of the second structural example.
[0019] Fig. 9 It is a top view showing the conductive sheet of the third configuration example.
[0020] Fig.10 It is a top view showing the conductive sheet of the fourth configuration example.
[0021] Fig.11 It is a bottom view showing the conductive sheet of the fifth configuration example.
[0022] Fig.12 (a) is a plan view showing a conductive sheet 1 according to a sixth configuration example. Fig.12 (b) is a side view showing the conductive sheet 1 of the sixth configuration example.
[0023] Fig.13 yes Fig.12 (a) is the cross-sectional view along line BB. DETAILED DESCRIPTION
[0024] The following will describe the embodiments of the present utility model in conjunction with the accompanying drawings. The various features shown in the following embodiments can be combined with each other.
[0025] The program for implementing the software appearing in this embodiment can be provided as a non-transitory computer-readable storage medium (Non-Transitory Computer-Readable Medium), can be downloaded and provided by an external server, and can also be started by an external computer to implement functions on a client terminal (the so-called cloud computing).
[0026] In addition, the term "unit" in this embodiment may be a concept including, for example, a combination of hardware resources implemented by a circuit in a broad sense and software information processing specifically implemented by these hardware resources. Moreover, various information is involved here, which can be represented by, for example, a physical value representing a signal value of voltage or current, or a high or low signal value as a binary bit set consisting of 0 or 1, or a quantum superposition (i.e., a so-called quantum bit), and communication and calculation can be performed on a circuit in a broad sense.
[0027] In addition, a circuit in a broad sense is a circuit realized by at least appropriately combining a circuit, a circuit type, a processor, and a memory, etc. That is, it includes an application-specific integrated circuit (ASIC), a programmable logic device (for example, a simple programmable logic device (SPLD), a complex programmable logic device (CPLD), and a field programmable gate array (FPGA)).
[0028] First, the skin treatment device of the present invention will be described.
[0029] Figure 1 It is a top view showing a disassembled state of the skin treatment device of this embodiment. Figure 2 It means that Figure 1 A top view of the device body after being turned inside out. Figure 3 It is a plan view showing a state in which the conductive sheet of the first structural example is disassembled. Figure 4 yes Figure 1 AA line section view in. Figure 5 This is a block diagram showing the structure of the device body.
[0030] In the following instructions, Figures 1 to 3 The front side of the paper is described as the "surface" or "top". Figures 1 to 3The back side of the paper is described as "inside" or "below". Figure 4 The upper side in the description is "table" or "upper", Figure 4 The lower side is described as "li" or "xia".
[0031] Figure 1 and Figure 2 The skin treatment device 100 shown is used by being attached to the user's skin. The skin treatment device 100 comprises a conductive sheet 1, at least a portion of which can be extended or retracted in any direction, and a device body 10 mounted to the conductive sheet 1 and supplying current to the user's skin.
[0032] <First Configuration Example>
[0033] First, a first configuration example of the conductive sheet 1 will be described.
[0034] like Figure 3 and Figure 4 As shown, the conductive sheet 1 comprises a sheet substrate 2, a conductive pattern 3 and a bioadhesive layer 4. Figure 1 and Figure 2 In FIG. 1 , the conductive pattern 3 located on the back side (lower side) of the sheet substrate 2 is indicated by oblique lines.
[0035] like Figure 1 and Figure 3 As shown, the sheet base material 2 has a pair of wide width portions 21 formed in a circular shape as a whole and a narrow width portion 22 connecting these wide width portions 21, and they are formed integrally. With such a structure, the sheet base material 2 has a dumbbell shape in a plan view.
[0036] In addition, an ear portion 23 is formed to protrude from the end of the wide portion 21 on the opposite side to the narrow portion 22. The skin treatment device 100 can be smoothly peeled off (removed) from the user's skin surface by grasping and operating the ear portion 23 with fingers or the like.
[0037] The sheet substrate 2 functions as a support layer for supporting the conductive pattern 3 and the bioadhesive layer 4. The sheet substrate 2 can be stretched or contracted in any direction.
[0038] As the sheet substrate 2, for example, resin sheets such as polyethylene terephthalate sheets, polypropylene sheets, and polyethylene sheets, thermoplastic elastomer sheets such as polyurethane thermoplastic elastomer sheets, rubber sheets such as nitrile rubber sheets and polyurethane rubber sheets, paper substrates, woven fabrics, non-woven fabrics, foam boards, etc., or laminated sheets formed by laminating these materials, etc. can be cited.
[0039] The thickness of the sheet substrate 2 is not particularly limited, but is preferably about 10 μm to about 200 μm, more preferably about 25 μm to about 150 μm, from the viewpoint of ensuring high conformability of the conductive sheet 1 to the skin surface.
[0040] The durometer hardness A of the sheet substrate 2 is preferably about 10 to about 80, more preferably about 30 to about 70. This can further increase the degree of deformation (bending, stretching, etc.) of the sheet substrate 2 and improve the friction durability or mechanical strength of the sheet substrate 2.
[0041] The durometer hardness A of the sheet base material 2 is obtained by preparing a sheet-like test piece using the sheet base material 2 in accordance with JIS K 6253 (1997), and measuring the durometer hardness A at 25°C.
[0042] The tear strength of the sheet substrate 2 is preferably about 25 N / mm to about 80 N / mm, and more preferably about 30 N / mm to about 70 N / mm. In this way, the durability of the sheet substrate 2 during repeated use can be improved. In addition, even if the sheet substrate 2 is made thinner, it can be made less likely to be damaged. Therefore, it is possible to achieve a balance between various characteristics of the sheet substrate 2 while improving the degree of freedom in design.
[0043] The tear strength of the sheet base material 2 is obtained by preparing a crescent-shaped test piece using the sheet base material 2 in accordance with JIS K6252 (2001) and measuring the tear strength at 25°C.
[0044] The elongation at break of the sheet substrate 2 is preferably 100% to 2000%, more preferably 200% to 1900%, and even more preferably 300% to 1800%. Thus, while achieving a balance of various properties of the sheet substrate 2, the high elasticity and durability of the sheet substrate 2 can be improved.
[0045] The elongation at break of the sheet substrate 2 can be calculated by preparing a dumbbell No. 3 test piece using the sheet substrate 2 according to JIS K 6251 (2004) and measuring its elongation at break at 25° C. as [distance between markings (mm)] ÷ [initial distance between markings (20 mm)]×100.
[0046] The tensile strength of the sheet substrate 2 is preferably about 5 MPa to about 25 MPa, and more preferably about 10 MPa to about 20 MPa. Thus, the mechanical strength of the sheet substrate 2 can be improved while achieving a balance of various characteristics of the sheet substrate 2. In addition, a sheet substrate 2 having excellent durability against repeated deformation can be achieved.
[0047] The tensile strength of the sheet base material 2 is obtained by preparing a dumbbell No. 3 test piece using the sheet base material 2 in accordance with JIS K 6251 (2004) and measuring the tensile strength thereof at 25°C.
[0048] The sheet substrate 2 preferably has high air permeability (high oxygen permeability, high water vapor permeability) so that the skin surface is less likely to be damaged when the skin treatment device 100 is used to treat the skin surface.
[0049] Specifically, the oxygen permeability of the sheet substrate 2 is not particularly limited, but is preferably 1×10 3 cm 3 / m 2 ·24h·atm or more, more preferably 2×10 3 cm 3 / m 2 ·24h·Above about atm.
[0050] The water vapor permeability of the sheet substrate 2 is also not particularly limited, but is preferably 5 g / m 2 ·24h·atm or more, more preferably 10g / m 2 ·24h·Above about atm.
[0051] Two through holes 221 and two openings 222 are formed in the sheet base 2 (narrow width portion 22 ).
[0052] The two through holes 221 are respectively inserted with Figure 2 The pin 101 of the device body 10 is shown. By inserting the pin 101 through the through hole 221, the device body 10 can be positioned relative to the conductive sheet 1. That is, the skin treatment device 100 includes a positioning portion for the device body 10 relative to the conductive sheet 1 composed of the pin 101 and the through hole 221.
[0053] In each opening 222, a portion of the conductive mode 3 is exposed. Figure 2 As shown, the device body 10 has a pair of terminal portions 11. When the device body 10 is positioned relative to the conductive sheet 1, the terminal portions 11 are inserted into the corresponding openings 222 and contact the conductive pattern 3. Thus, the device body 10 and the conductive pattern 3 are electrically connected.
[0054] The conductive pattern 3 is provided on the lower side (one side) of the sheet substrate 2. The conductive pattern 3 may be arranged in direct contact with the sheet substrate 2, or may be arranged via an intermediate layer of any purpose. As the function of the intermediate layer, for example, a function of improving the adhesion between the conductive pattern 3 and the sheet substrate 2, a function of reinforcing the conductive pattern 3, a function other than energization (for example, a heating function and a magnetic force applying function described later) and the like may be cited.
[0055] like Figure 3As shown, the conductive pattern 3 is provided as a pair of left and right conductive patterns 3, and the two conductive patterns 3 have substantially the same shape. Each conductive pattern 3 includes three wiring portions 31 and an electrode portion 32 connected to one end of each wiring portion 31. In this way, by dividing and arranging the electrode portion 32, it is easier to evenly supply current to the skin surface.
[0056] Furthermore, the three wiring portions 31 merge at the other ends thereof to form a merging portion 33 .
[0057] The connecting portion 34 further protrudes toward the other end side from the merging portion 33 and is formed integrally. As described above, the sheet base material 2 has the opening 222 through which the connecting portion 34 is exposed.
[0058] When the device body 10 is mounted on the conductive sheet 1, the terminal portion 11 is inserted into the corresponding opening portion 222 and contacts the connection portion 34. That is, the wiring portion 31 has the connection portion 34 connected to one of the terminal portions 11 at the other end side.
[0059] Such a conductive pattern 3 can also be stretched and contracted in any direction.
[0060] For example, the conductive pattern 3 may be composed of a composite material (stretchable conductive material) including a conductive filler and an elastomer.
[0061] Examples of the conductive filler include carbon materials such as carbon nanotubes and carbon nanohorns, and metal materials such as gold, silver, copper, and nickel.
[0062] Examples of the elastomer include thermoplastic elastomers such as polyamide-based thermoplastic elastomers, polyester-based thermoplastic elastomers, and polyurethane-based thermoplastic elastomers, and rubber materials such as ethylene propylene rubber, chloroprene rubber, natural rubber, and silicone rubber.
[0063] With such a composite material, the conductive pattern 3 can be produced relatively easily using a printing method.
[0064] The thickness of the conductive pattern 3 is not particularly limited, but is preferably about 1 μm to about 50 μm, and more preferably about 5 μm to about 25 μm, from the viewpoint of ensuring high followability of the conductive sheet 1 to the skin surface and mechanical strength of the conductive pattern 3 .
[0065] When the resistance value (at 25°C) of the conductive pattern 3 in the non - stretched (natural state) as a whole with the bio - adhesive layer 4, or the conductive pattern 3 alone is set as R1 [Ω], and the resistance value (at 25°C) of the conductive pattern 3 in the 50% stretched state as a whole with the bio - adhesive layer 4, or the conductive pattern 3 alone is set as R2 (Ω), it is preferably that the relationship 1 < R2 / R1 ≤ 20 is satisfied, more preferably that the relationship R2 / R1 ≤ 18 is satisfied, and further preferably that the relationship R2 / R1 ≤ 16 is satisfied. If the change in the resistance value is within this range, current can be stably supplied to the skin surface.
[0066] When measuring the resistance value between the lower surface (skin - side surface) of the bio - adhesive layer 4 or, when the bio - adhesive layer 4 is omitted, the lower surface (skin - side surface) of the conductive pattern 3 and the upper surface (connection to the power source) of the connection portion 34, R1 is preferably about 1000 Ω or less, more preferably about 600 Ω or less, further preferably about 500 Ω or less, particularly preferably about 400 Ω or less, and most preferably about 300 Ω or less. R2 is preferably about 5000 Ω or less, more preferably about 2000 Ω or less, and further preferably about 1500 Ω or less.
[0067] In this specification, the stretchability of the conductive pattern 3 is represented by the elongation rate when the conductive pattern 3 is stretched in a certain direction. As the certain direction, for example, it can be set as the extending direction in which the wiring portion 31 extends.
[0068] When the conductive pattern 3 is extended along this extending direction, the elongation rate is preferably about 10% or more, more preferably about 20% or more, further preferably about 50% or more, and it means that when extended at this elongation rate, the conductive pattern 3 does not break. For the conductive pattern 3 that satisfies this condition, it can be judged to have stretchability.
[0069] In addition, as Figure 1 and Figure 2 shown, a part of the wiring portion 31 and the electrode portion 32 is arranged along the outer edge of the sheet substrate 2. Thereby, current can be supplied more uniformly to the skin area where the conductive sheet 1 is pasted.
[0070] The bio - adhesive layer 4 is provided on the side opposite to the sheet substrate 2 of the conductive pattern 3. The bio - adhesive layer 4 is configured to be pasted on the skin surface of the user. That is, the bio - adhesive layer 4 has the function of holding the entire skin treatment device 100 on the skin surface of the user.
[0071] The adhesive force of the bioadhesive layer 4 slightly varies depending on the shape or size of the conductive pattern 3, and is preferably about 0.5 N / 20 mm to about 10 N / 20 mm, and more preferably about 1 N / 20 mm to about 6 N / 20 mm. If the bioadhesive layer 4 has an adhesive force within this range, the conductive pattern 3 can be more reliably held on the user's skin surface.
[0072] The adhesive strength of the bioadhesive layer 4 refers to the adhesive strength at 90° peeling according to the adhesive tape test method of JIS Z 0237:2009.
[0073] like Figure 3 As shown, the bioadhesive layer 4 is also provided as a pair on the left and right, and the two bioadhesive layers 4 have substantially the same shape. Each bioadhesive layer 4 has a size that includes the conductive pattern 3 when viewed from above. In this way, by covering the entire conductive pattern 3 with the bioadhesive layer 4, it is easier to evenly supply current to the skin surface.
[0074] The bioadhesive layer 4 can be obtained by supplying a bioadhesive layer forming material to a release sheet before gelation to form a coating and crosslinking the coating. Alternatively, the bioadhesive layer forming material before gelation can be supplied to cover the conductive pattern 3 and crosslinked.
[0075] Examples of the cross-linking (polymerization) method include a method of heating, light irradiation, or radiation irradiation of the bioadhesive layer-forming material.
[0076] This bioadhesive layer 4 can also stretch and contract in any direction.
[0077] The bioadhesive layer 4 is preferably a gel having adhesive force to the skin surface, and is particularly preferably an adhesive gel having a high water content. That is, the bioadhesive layer 4 is preferably in a gel state.
[0078] The water content of the high water content adhesive gel is not particularly limited, but is preferably about 10% to about 60% by mass, and more preferably about 15% to about 50% by mass. When the water content of the bioadhesive layer 4 is moderate, the swelling of the bioadhesive layer 4 is suppressed when the skin external preparation is used in combination, and the decrease in the adhesion of the conductive pattern 3 can be prevented or suppressed.
[0079] The high-water content adhesive gel is preferably a hydrogel, which contains a polymer matrix and a plasticizer in addition to water, and electrolytes and water-soluble polymers when necessary. The high-water content adhesive gel may also contain the active ingredients contained in the skin external preparation described below. In this case, a plurality of fine needle-like protrusions (height: about 50 μm or more and about 150 μm or less) can be formed on the skin side of the bioadhesive layer 4. In this way, when the bioadhesive layer 4 is attached to the skin surface, the plurality of protrusions penetrate the skin surface, thereby promoting the penetration of the active ingredients into the skin tissue (skin tissue).
[0080] (Polymer Matrix)
[0081] The polymer matrix is not particularly limited as long as it is formed of a mesh structure and is composed of a polymer compound obtained by forming a gel by containing at least water. In the present invention, it is preferred to use a polymer compound that allows adhesion to the skin surface. As the polymer compound, a copolymer of a monofunctional monomer having one ethylenically unsaturated group and a crosslinking monomer is particularly preferred.
[0082] Examples of the monofunctional monomer include (meth)acrylamide monomers, (meth)acrylate monomers, (meth)acrylic acid or its salts, etc. These monofunctional monomers may be used alone or in combination of two or more.
[0083] Specific examples of (meth)acrylamide monomers include: N,N-dialkyl (meth)acrylamide, such as (meth)acrylamide, N,N-dimethyl (meth)acrylamide, and N,N-diethyl (meth)acrylamide; N-alkyl (meth)acrylamide, such as N-isopropyl (meth)acrylamide, N-methyl (meth)acrylamide, N-ethyl (meth)acrylamide, and N-propyl (meth)acrylamide; (meth)acrylamide, such as N-hydroxyethyl (meth)acrylamide, and N-hydroxyalkyl N-hydroxymethyl (meth)acrylamide; amino group-containing cationic monomers, such as dimethylaminopropyl (meth)acrylamide; sulfonic acid group-containing anionic monomers, such as tert-butyl acrylamide sulfonic acid, or their salts; and derivatives thereof.
[0084] Specific examples of the (meth)acrylate monomer include: (meth)acrylate alkyl esters having an alkyl group having 1 to 18 carbon atoms, such as methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, and tert-butyl (meth)acrylate; (meth)acrylates containing an alkoxy group, such as 2-methoxyethyl (meth)acrylate, ethoxyethoxyethyl (meth)acrylate, and methoxytriethylene (meth)acrylate; (meth)acrylate hydroxyalkyl esters, such as 2-hydroxyethyl (meth)acrylate and 2-hydroxypropyl (meth)acrylate; glycerol mono(meth)acrylate; polyalkylene glycol mono(meth)acrylates, such as polyethylene glycol mono(meth)acrylate; and (meth)acrylates having an aromatic ring, such as benzyl (meth)acrylate.
[0085] Specific examples of (meth)acrylic acid or a salt thereof include acrylic acid, methacrylic acid, sodium acrylate, potassium acrylate, potassium methacrylate, and the like.
[0086] In the hydrogel, the total content of the structural units derived from the monofunctional monomers is preferably about 10% by mass to about 50% by mass, and more preferably about 15% by mass to about 45% by mass, relative to the total mass of the hydrogel. By setting the total content of the structural units derived from the monofunctional monomers in the hydrogel to the above range, the softness of the hydrogel can be further improved while maintaining a sufficient shape of the hydrogel.
[0087] As crosslinking monomers, for example, compounds having two or more polymerizable carbon-carbon double bonds in the molecule can be cited. Specific examples of such compounds include divinylbenzene, divinylbiphenyl, N,N'-methylenebis(meth)acrylamide, ethylene glycol di(meth)acrylate, glycerol tri(meth)acrylate, polyethylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, etc. These crosslinking monomers can be used alone or in combination of two or more.
[0088] In the hydrogel, the content of the structural unit derived from the crosslinkable monomer slightly varies depending on the types of the monofunctional monomer and the crosslinkable monomer used, and is therefore not particularly limited, but is preferably about 0.01% by mass to about 0.5% by mass, and more preferably about 0.01% by mass to about 0.1% by mass, relative to the total mass of the hydrogel. By setting the content of the structural unit derived from the crosslinkable monomer in the hydrogel to the above range, the crosslinking density can be sufficiently increased, thereby preventing or suppressing the gel from becoming too hard while maintaining the shape stability of the gel.
[0089] (Plasticizer)
[0090] Plasticizers are components added for the purpose of imparting water retention to the hydrogel, inhibiting the evaporation of water, maintaining the softness of the gel, etc. As the plasticizer, polyoxyalkylene alkyl ethers and / or sugars are preferably used. These compounds are more hydrophobic than polyols, and thus can reduce the infiltration of water into the hydrogel from the outside, preventing or inhibiting the swelling of the gel.
[0091] Specific examples of the polyoxyalkylene alkyl ethers include polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, polyoxyethylene isostearyl ether and the like; and polyoxypropylene lauryl ether, polyoxypropylene stearyl ether, polyoxypropylene isostearyl ether and the like; and the like.
[0092] Sugars are classified into monosaccharides, disaccharides or polysaccharides, and any one of them may be used alone or in combination of two or more.
[0093] Examples of the monosaccharide include xylose, arabinose, glucose, galactose, and mannose.
[0094] Examples of the disaccharides include sucrose, maltose, cellulose, and lactose.
[0095] Examples of the polysaccharides include oligosaccharides such as maltotriose, magnolia, starch, cellulose, chitin, chitosan, and the like.
[0096] In addition, amino sugars of these sugars and N-acetylated products thereof can also be used.
[0097] The content of the plasticizer is preferably about 10% by mass to about 60% by mass, and more preferably about 20% by mass to about 50% by mass, relative to the total mass of the hydrogel. By setting the content of the plasticizer in the hydrogel to the above range, it is possible to prevent the plasticizer from seeping out to the surface of the gel, stabilize the gel for a long time, and maintain the adhesive force of the gel.
[0098] The ratio of the polymer matrix to the plasticizer is preferably about 0.25:1 to about 3:1, and more preferably about 0.45:1 to about 2.5:1, in terms of mass ratio.
[0099] (Electrolytes)
[0100] The electrolyte is a component added for the purpose of imparting conductivity to the hydrogel.
[0101] Examples of the electrolyte include inorganic salts, organic salts, polymer salts, and mixtures thereof.
[0102] Specific examples of the inorganic salts include alkali metal halides, alkaline earth metal halides, other metal halides, hypochlorites, chlorites, chlorates, perchlorates, sulfates, carbonates, nitrates, phosphates, ammonium salts, complex salts and the like.
[0103] Specific examples of organic salts include metal salts of carboxylic acids such as acetic acid, benzoic acid, lactic acid, tartaric acid, phthalic acid, succinic acid, adipic acid, and citric acid, metal salts of sulfonic acids, metal salts of amino acids, and organic ammonium salts.
[0104] Specific examples of polymer salts include salts of poly(meth)acrylic acid, salts of polyvinylsulfonic acid, salts of poly-tert-butylacrylamidesulfonic acid, salts of polyallylamine, and salts of polyethyleneimine.
[0105] The electrolyte content is preferably about 0.001 mass % to about 10 mass % relative to the total mass of the hydrogel, and more preferably about 0.1 mass % to about 5 mass %. By setting the electrolyte content in the hydrogel within the above range, the impedance (Z) of the hydrogel can be prevented from increasing, and the hydrogel can be given sufficient conductivity.
[0106] In addition, electrolytes may be added for the purpose of adjusting the pH of the hydrogel, improving the moisture retention performance of the hydrogel, imparting antibacterial properties to the hydrogel, and the like.
[0107] (Water-soluble polymer)
[0108] The water-soluble polymer is a component added for the purpose of imparting adhesiveness to the hydrogel.
[0109] Examples of the water-soluble polymer include polyvinyl pyrrolidone, vinyl pyrrolidone copolymers, polyvinyl alcohol, polyacrylic acid, sodium polyacrylate, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, sodium alginate, and dextrin, etc. These water-soluble polymers may be used alone or in combination of two or more.
[0110] Among them, as the water-soluble polymer, polyacrylic acid and / or sodium polyacrylate are preferred because they are excellent in the effect of imparting adhesiveness to the hydrogel.
[0111] The content of the water-soluble polymer is preferably about 0.1% by mass or more and 5% by mass or less relative to the total mass of the hydrogel.
[0112] (Other additives)
[0113] As long as the effects of the present invention are not impaired, other ingredients such as preservatives, bactericides, rust inhibitors, antioxidants, stabilizers, fragrances, surfactants, colorants, anti-inflammatory agents, vitamins, and whitening agents may be appropriately added to the hydrogel as needed. These additives may be used alone or in combination of two or more.
[0114] The content of these additives is preferably about 0.01% by mass or more and 10% by mass or less relative to the total mass of the hydrogel.
[0115] Such a hydrogel can be produced, for example, in the following manner.
[0116] When the polymer matrix is composed of a polymer of a monofunctional monomer and a crosslinking monomer, it can be easily prepared by copolymerizing the monofunctional monomer and the crosslinking monomer in a formulation prepared by uniformly mixing and dissolving the monofunctional monomer, the crosslinking monomer and a plasticizer in water.
[0117] If necessary, a water-soluble polymer, an electrolyte and / or other additives may be added to the formulation liquid.
[0118] Alternatively, the polymer matrix formed by polymerizing a monofunctional monomer and a crosslinking monomer in advance may be impregnated with water and a plasticizer, and if necessary, a water-soluble polymer, an electrolyte and / or other additives.
[0119] The polymerization of the monofunctional monomer and the crosslinkable monomer is preferably carried out in the presence of a polymerization initiator. Examples of the polymerization initiator that can be used include a thermal polymerization initiator and a photopolymerization initiator.
[0120] As the thermal polymerization initiator, a compound that generates free radicals by thermal cracking can be used. Examples of the thermal polymerization initiator include benzoyl peroxide, azobiscyanovaleric acid, azobisisobutyronitrile, azodiaminopropane dihydrochloride, potassium persulfate, ammonium persulfate, etc. These thermal polymerization initiators can be used alone or in combination of two or more.
[0121] As necessary, a redox initiator composed of a reducing agent such as ferrous sulfate, pyrosulfite, and a peroxide such as hydrogen peroxide, sodium thiosulfate, and peroxodisulfate may be used together with the thermal polymerization initiator.
[0122] As the photopolymerization initiator, a compound that generates free radicals by cleavage with ultraviolet light or visible light can be used. Examples of the photopolymerization initiator include azo-based polymerization initiators such as 2,2'-azobis-N-(2-hydroxyethyl)propionamide and 2,2'-azobis(1-imino-1-pyrrolidinyl-2-methylpropane) dihydrochloride, α-hydroxyketones, α-aminoketones, benzyl methyl ketal, bisacylphosphine oxide, and metallocenes.
[0123] Specific examples of the photopolymerization initiator include 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-propane-1-one, 2-hydroxy-2-methyl-1-phenyl-propane-1-one, 1-hydroxy-cyclohexyl-phenyl-ketone, 2-methyl-1-[(methylthio)phenyl]-2-morpholinylpropane-1-one, 2-benzyl-2-dimethylamino-1-(4-morpholine)-butane-1-one, etc. These photopolymerization initiators may be used alone or in combination of two or more.
[0124] The content of the polymerization initiator is preferably about 0.01% by mass to about 1% by mass, and more preferably about 0.05% by mass to about 0.5% by mass, relative to the total mass of the hydrogel (the total mass of the material for forming the bioadhesive layer). By setting the content of the polymerization initiator in the hydrogel to the above range, the polymerization reaction can be fully carried out, and the amount of the monofunctional monomer and the cross-linking monomer remaining in the obtained hydrogel can be reduced. In addition, discoloration (yellowing) or odor caused by the polymerization initiator remaining in the obtained hydrogel can be prevented.
[0125] The thickness of the bioadhesive layer 4 is not particularly limited, but is preferably about 50 μm to about 500 μm, more preferably about 100 μm to about 350 μm, from the viewpoint of ensuring high conformability of the conductive sheet 1 to the skin surface and mechanical strength of the bioadhesive layer 4 .
[0126] In addition, the bioadhesive layer 4 is not limited to a configuration that covers the entire conductive pattern 3, but may also be a configuration that covers a portion of the conductive pattern 3. In the latter case, in the conductive sheet 1, the conductive pattern 3 is directly in close contact with the skin surface in the portion where the bioadhesive layer 4 is not present, and the bioadhesive layer 4 is directly in close contact with the skin in the portion where the bioadhesive layer 4 is present. In this case, due to the presence of the bioadhesive layer 4, the conductive sheet 1 can be reliably maintained in a state of being attached to the skin surface of the user, while applying muscle stimulation based on a stronger current to the skin surface to which the conductive pattern 3 is directly in close contact.
[0127] In addition, the conductive sheet 1 only needs to have at least a portion that can be stretched in any direction. Therefore, the conductive sheet 1 may include a portion that is stretchable as the entire conductive sheet 1 and a portion that is not stretchable, such as a mode in which the sheet substrate 2 is stretchable but the conductive pattern 3 is not necessarily stretchable, or a mode in which the sheet substrate 2 and / or the conductive pattern 3 include a portion that is stretchable and a portion that is not stretchable.
[0128] Furthermore, the conductive sheet 1 may be configured to be non-stretchable, and at least a portion thereof may be flexible enough to follow the skin surface. In this case, the range of choices for the material used for the sheet base material 2 and the conductive pattern 3 can be expanded.
[0129] The device main body 10 is mounted on the conductive sheet 1 .
[0130] In the first configuration example, the conductive sheet 1 is in an elongated shape, and the device body 10 is attached to the center portion (narrow width portion 22 ) of the conductive sheet 1 in the longitudinal direction.
[0131] As described above, the pair of pins 101 and the pair of terminal portions 11 protrude from the back surface of the device body 10. The pair of pins 101 are respectively inserted through the corresponding through holes 221 formed in the narrow width portion 22 of the sheet base material 2. The pair of terminal portions 11 are respectively inserted through the corresponding openings 222 formed in the narrow width portion 22 of the sheet base material 2. Thus, the device body 10 is connected (fixed) to the conductive sheet 1.
[0132] With such a configuration, in this embodiment, the device body 10 is detachably mounted on the conductive sheet 1. Alternatively, the device body 10 may be fixed to the conductive sheet 1 in an irremovable manner.
[0133] When the device body 10 is configured to be detachable relative to the conductive sheet 1, it is preferred that the device body 10 is attached to the conductive sheet 1 by magnetic force. For example, by arranging a permanent magnet inside or on the back of the device body 10, the permanent magnet can be attracted to the conductive pattern 3 by magnetic force. This attachment and detachment mechanism has a simple structure, which helps prevent the device body 10 from being enlarged.
[0134] In addition, when the device body 10 is configured to be attracted to the conductive sheet 1 by magnetic force, by configuring permanent magnets with different polarities (S pole and N pole) on both the device body 10 and the conductive sheet 1, it is possible to prevent the device body 10 from being installed reversely relative to the conductive sheet 1.
[0135] In addition, the device body 10 may be configured to be mounted on the end of the length direction of the conductive sheet 1. In this case, the wiring portion 31 is extended to the end of the sheet base 2, and the connecting portion 34 is connected to the tip thereof. This configuration can also be applied to the conductive sheet 1 of other configurations described later and the conductive sheet 1 of the second configuration example.
[0136] Furthermore, the device body 10 is preferably as small as possible and is required to have a quality that does not hinder the close contact with the skin surface. Therefore, the device body 10 is made lighter and smaller by using a flexible substrate.
[0137] In this case, the skin treatment device 100 preferably includes a plurality of conductive sheets 1 of different types, and the device body 10 is detachably mounted on each conductive sheet 1. Thus, an appropriate conductive sheet 1 can be selected and used according to the area of the skin surface to be treated, thereby more easily and reliably performing skin treatment in accordance with the user's requirements. A second configuration example of the conductive sheet 1 will be described later.
[0138] like Figure 5 As shown, two operation buttons 12 are provided on the surface of the device body 10. These operation buttons 12 can change at least one of the power supply amount or the power supply mode (Pattern / Mode). In addition, the change of the power supply amount also includes the on / off of the power supply (power source).
[0139] In addition, a power supply unit 13, a control unit 14, and a circuit unit 15 are provided inside the device body 10. The power supply unit 13, the circuit unit 15, and the two operation buttons 12 are electrically connected to the control unit 14, and the two terminal units 11 are electrically connected to the circuit unit 15.
[0140] The power supply unit 13 is configured to supply power to the electrode unit 32. The power supply unit 13 may be, for example, a dry cell, a solar cell, a fuel cell, a lithium ion secondary battery, a solid-state battery, a lithium polymer battery, etc. The power supply unit 13 may also be a connector to which a power cable can be connected.
[0141] The control unit 14 has a built-in computing element and a storage element.
[0142] The computing element is composed of, for example, a CPU (Central Processing Unit), an MPU (MicroProcessing Unit), etc. The computing element realizes various functions related to the skin treatment device 100 by reading a predetermined program stored in the storage element. That is, the information processing by the software stored in the storage element is specifically realized by the computing element.
[0143] Furthermore, the number of computing elements is not limited to a single one, and a plurality of computing elements may be provided for each function. Furthermore, a combination of these may be used.
[0144] The storage element stores various information defined according to the above description. This can be implemented, for example, as a storage device such as a solid state drive (SSD) that stores various programs of the skin treatment device 100 executed by the computing element, or as a memory such as a random access memory (RAM) that stores temporary necessary information (parameters, sequences, etc.) involved in the operation of the program.
[0145] In addition, the storage element stores various programs and variables of the skin treatment device 100 executed by the computing element.
[0146] The circuit unit 15 includes, for example, a drive circuit, an output waveform generating circuit, a transformer, a switching circuit, and the like.
[0147] The control unit 14 is configured to control the power supplied from the power supply unit 13 to the electrode unit 32 via the circuit unit 15. Here, the control of power refers to setting at least one of voltage value, current value, waveform, frequency, pulse width, energization direction and energization time.
[0148] In this embodiment, under the control of the control unit 14, the current supplied by the device body 10 is at least one of a current for promoting the penetration of active ingredients contained in the skin external preparation, a current for imparting muscle stimulation, a current for heating the skin surface, and a microcurrent.
[0149] The kind (mode) of the electric current supplied from the device main body 10 can be changed by operating the operation button 12 .
[0150] It is best to use a current having multiple pulse waveforms to promote the penetration of the active ingredients contained in the skin external preparation. In this way, the active ingredients contained in the skin external preparation can be penetrated into the skin tissue more quickly.
[0151] For example, the frequency of the current having the first pulse waveform is preferably about 1.5 kHz±10%, and the voltage is preferably about 20 V or less. In this case, it is more preferable to generate a pulse with reversed polarity once for multiple pulses (for example, 7 pulses) of the same polarity.
[0152] The current having the second pulse waveform preferably has a frequency of about 1 Hz to about 1 kHz, and a voltage of about 20 V to about 50 V.
[0153] The order in which these two types of current are supplied to the skin surface is arbitrary, but is preferably alternating.
[0154] The combination of electric currents is not limited thereto, and it is preferred to combine stimulations according to the purpose, the penetrating components, and the user's body sensation preference to promote the penetration of the active ingredients contained in the skin external preparation.
[0155] For example, a current having a third pulse waveform may be used. In this case, the current preferably has a frequency of about 10 Hz to about 100 Hz, and a voltage of about 50 V or more.
[0156] By combining the current having the first pulse waveform and the current having the third pulse waveform, the device can be used with a mild stimulation even when it is attached to the skin surface.
[0157] In addition, the current having a variety of pulse waveforms may include a current having a frequency of 1 kHz and a current having a plurality of frequencies, mainly a current having a frequency of about 10 Hz to about 50 Hz (muscle potential stimulation).
[0158] The current for promoting the penetration of the active ingredient contained in the external skin preparation is not limited to the combination of currents having a plurality of pulse waveforms, and a current having a single waveform for ion introduction may be used alone or in combination with a current having at least one arbitrary pulse waveform.
[0159] The current applied for electrical muscle stimulation (EMS) preferably has a frequency of about 1 Hz to about 1 kHz, which causes the muscles to contract, thereby achieving muscle movement and relieving tension.
[0160] The frequency of the electric current (high-frequency current) for heating the skin surface is preferably about 10 kHz or more, and more preferably about 10 kHz or more and 500 kHz or less.
[0161] The frequency of the microcurrent is preferably about 1200 Hz or less.
[0162] Examples of active ingredients contained in the external skin preparation used together with the skin treatment device 100 include the following compounds.
[0163] Specific examples of active ingredients include tranexamic acid or its derivatives (tranexamic acid hexadecyl hydrochloride, etc.), niacinamide, pyridoxine hydrochloride or its derivatives, benzyl chloride, palmitoyl tripeptide-5, acetyl hexapeptide-8, diacetate dipeptide diaminobutyryl benzylamide or its derivatives, urea, alkanes, alkanedioxybenzoyl HCl, urea, etc.
[0164] Other examples of active ingredients include, in addition to potassium 4-methoxysalicylate and disodium adenosine monophosphate, ascorbic acid or its derivatives (L-ascorbic acid 2-glucoside, sodium L-ascorbyl phosphate, disodium L-ascorbyl sulfate, trisodium ascorbyl palmitate phosphate, etc.), sodium dl-α-tocopherol phosphate, zinc p-phenolsulfonate, salicylic acid and its sodium salt, sodium lactate, sodium L- or DL-pyrrolidonecarboxylate, sodium L-glutamate, sodium L-aspartate, glycyrrhizic acid or its sodium salt (dipotassium glycyrrhizinate, ammonium glycyrrhizinate, etc.), sodium guaiazulene oil sulfonate, sodium dilauroyl glutamate lysine, etc.
[0165] Other examples of active ingredients include kojic acid, arbutin, hydroquinone, 4-n-butylresorcinol, 5,5'-dipropylbiphenyl-2,2'-diol, ellagic acid, ascorbic acid derivatives (3-O-ethyl ascorbic acid, 3-glyceryl ascorbic acid, diglyceryl ascorbic acid, hexyl 3-glyceryl ascorbic acid, myristyl 3-glyceryl ascorbic acid, 3-laurylglyceryl ascorbic acid, etc.), D-panthenol, cholecalciferol, 3-o-cymene-5-ol (isopropylmethylphenol), glycine, proline, alanine, serine, acetylhydroxyproline, ε-aminocaproic acid, γ-aminobutyric acid, trimethylglycine, xylose, sorbitol, mannitol, butylene glycol, hexylene glycol, pentylene glycol, glycerin, and hinokitiol.
[0166] Other examples of active ingredients include fullerene, orlistat, ceramide EOP, ceramide EOS, ceramide NG, hexanoyl sphingomyelin, ceramide NP, N-stearoyl dihydrosphingomyelin, ceramide AG, ceramide AP, hydroxysemistearoyl sphingomyelin, ceramide 6II, phytosphingomyelin (liposomal inclusion or non-inclusion), flavonoids (isoflavonoids, licorice root extract, licorice flavonoids, licorice flavonoids, etc.), extracts obtained from plants or animals (chamomile ET, kra root extract, cactus extract, carrot or its root extract, soybean extract, soybean seed extract, caryophyllene leaf extract, galactoside culture solution, rice extract No. 11, astaxanthin solution, red algae extract, placenta extract, etc.), stem cell culture solution, stem cell culture supernatant, etc.
[0167] Other examples of active ingredients include squalane, linoleic acid, tetrahexyldecyl ascorbate, ascorbyl dipalmitate, retinol or its derivatives (retinyl acetate, retinyl palmitate, hydrogenated retinol, retinyl linoleate, etc.), tocopherol (natural vitamin E) or its derivatives (nicotinic acid tocopherol, dl-α-tocopherol, d-δ-tocopherol, DL-α-tocopherol acetate, etc.), stearyl glycyrrhetinate, estradiol, ethinyl estradiol, astaxanthin, rice germ oil, phospholipids (sphingomyelin, etc.), synthetic or plant-containing squalane, guaiazulene, guaiazulene sulfonate, ascorbic acid fatty acid esters (ascorbyl stearate, ascorbyl palmitate, etc.), di(phytosteryl / octyldodecyl) lauroyl glutamate, oil-soluble placenta, etc.
[0168] Other examples of active ingredients include human recombinant oligopeptide-1, palmitoyl hexapeptide (palmitoyl hexapeptide-4, etc.), palmitoyl pentapeptide, hydrolyzed collagen or its derivatives, hyaluronic acid or its derivatives (sodium hyaluronate, acetylated sodium hyaluronate), albumin fungal polysaccharide, alkali-producing polysaccharide, polyquaternary ammonium salt, etc.
[0169] The bioadhesive layer 4 can well retain the compound.
[0170] In addition, the current that promotes the penetration of the active ingredient contained in the skin external preparation may also be an alternating current. For example, an alternating current (AC stimulation) of an appropriate frequency may be applied to the skin surface according to the characteristics of the active ingredient, thereby promoting the penetration of the active ingredient.
[0171] When the active ingredient is a low molecular weight substance that is water-soluble and easily positively charged in an aqueous solution (such as tranexamic acid), the frequency of the alternating current is preferably between 10 kHz and 200 kHz, and more preferably between 50 kHz and 180 kHz.
[0172] When the active ingredient is a low molecular weight substance that is water-soluble and easily negatively charged in an aqueous solution (such as 4-methoxysalicylic acid potassium salt), the frequency of the alternating current is preferably between 10 kHz and 200 kHz, and more preferably between 50 kHz and 160 kHz.
[0173] In addition, when the active ingredient is a low molecular weight substance that is water-soluble and has almost no charge in the aqueous solution (kojic acid, arbutin, etc.) or amphoteric electrolyte (amino acid, peptide), a lipid and oil-soluble substance (squalane, etc.), or a high molecular weight substance (human genetically modified oligopeptide-1, etc.), depending on the nature of the active ingredient, the penetration of the active ingredient into the skin tissue can also be promoted by giving appropriate stimulation.
[0174] like Figure 6 and Figure 7 As shown, the bioadhesive layer 4 may be provided corresponding to the plan view shape of the conductive pattern 3. Specifically, the plan view shape of the bioadhesive layer 4 may be consistent with the plan view shape of the conductive pattern 3, or may be set slightly larger.
[0175] Figure 6 It is a plan view showing a state where a conductive sheet having a bioadhesive layer of another structure is disassembled. Figure 7 yes Figure 6 The conductive sheet and Figure 4 The corresponding cross-sectional view.
[0176] In addition, in the following description, Figure 6 The front side of the paper is described as the "surface" or "top". Figure 6 The back side of the paper is described as "inside" or "below". Figure 7 The upper side in the description is "table" or "upper", Figure 7 The lower side is described as "li" or "xia".
[0177] According to such a configuration, when a skin external preparation is used in combination, the skin external preparation is held in the slits 3a of the conductive pattern 3 and the slits 4a of the bioadhesive layer 4, and scattering can be prevented or suppressed. In this state, if a current that promotes the penetration of the active ingredient contained in the skin external preparation is supplied to the skin surface via the electrode portion 32, the penetration efficiency of the active ingredient can be further improved.
[0178] Regarding the skin treatment device 100, the area of the conductive sheet 1 in a plan view is denoted as A [mm 2 ], the area of the device body 10 when viewed from above is set to B [mm 2 ], B / A is preferably about 0.1 to about 0.6, and more preferably about 0.2 to about 0.5. Thus, the size of the conductive sheet 1 and the size of the device body 10 can be balanced.
[0179] In addition, the bioadhesive layer 4 may not be arranged to correspond to the shape of the conductive pattern 3 when viewed from above, for example, it may have a shape and / or size that covers the entire conductive pattern 3, or may have a shape and / or size that exposes a portion of the conductive pattern 3.
[0180] <Second Configuration Example>
[0181] Next, a second configuration example of the conductive sheet 1 will be described.
[0182] Hereinafter, the conductive sheet 1 of the second configuration example will be described mainly with respect to the differences from the conductive sheet 1 of the first configuration example described above, and descriptions of the same matters will be omitted.
[0183] Figure 8 It is a top view showing a disassembled state of the skin treatment device including the conductive sheet of the second structural example.
[0184] In addition, in the following description, Figure 8 The front side of the paper is described as the "surface" or "top". Figure 8 The back side of the paper is described as "inside" or "below". Figure 8 In FIG. 1 , the conductive pattern 3 located on the back side (lower side) of the sheet base 2 is indicated by oblique lines.
[0185] The conductive sheet 1 of the second configuration example is in an elongated shape, and is formed so that the width at one end is larger than the width at the other end. The device body 10 is configured to be attached to one end of the conductive sheet 1 .
[0186] In addition, the conductive sheet 1 is bent in the middle of its longitudinal direction.
[0187] The conductive sheet 1 having such a structure can be appropriately used by sticking it around the eyes or on the skin surface with obvious nasolabial folds.
[0188] In this way, a suitable conductive sheet 1 can be selected according to the area of the skin surface to be treated, and the device body 10 can be installed for use, so that skin treatment corresponding to the user's requirements can be performed more easily and more reliably.
[0189] <Third Configuration Example>
[0190] Next, a third configuration example of the conductive sheet 1 will be described.
[0191] Hereinafter, the conductive sheet 1 of the third configuration example will be described mainly with respect to the differences from the conductive sheets 1 of the first and second configuration examples described above, and descriptions of the same matters will be omitted.
[0192] Fig. 9 It is a plan view showing the conductive sheet 1 according to the third configuration example.
[0193] In the following instructions, Fig. 9 The front side of the paper is described as the "surface" or "top". Fig. 9 The back side of the paper is described as "inside" or "below". Fig. 9 In FIG. 1 , the conductive pattern 3 located on the back side (lower side) of the sheet base 2 is indicated by oblique lines.
[0194] The conductive sheet 1 of the third configuration example is in an elongated shape and is bent in the middle of its longitudinal direction to form a C-shape or an L-shape.
[0195] The conductive sheet 1 of this structure can contact the frontalis muscle, temporalis muscle and orbicularis oculi muscle at the same time, so that skin treatment can be easily performed on the area.
[0196] In addition, the tip portion 35 of each conductive pattern 3 on the opposite side of the connecting portion 34 is in a mesh shape. With the tip portion 35 having such a shape, the current applied to the skin surface can be dispersed in this portion (in other words, current concentration can be prevented). In this way, the user can get a gentle body sensation (muscle stimulation), that is, there will be no uncomfortable body sensation.
[0197] <Fourth Configuration Example>
[0198] Next, a fourth configuration example of the conductive sheet 1 will be described.
[0199] Hereinafter, the conductive sheet 1 of the fourth configuration example will be described mainly with respect to the differences from the conductive sheets 1 of the first to third configuration examples described above, and descriptions of the same matters will be omitted.
[0200] Fig.10 It is a plan view showing the conductive sheet 1 according to the fourth configuration example.
[0201] In the following instructions, Fig.10 The front side of the paper is described as the "surface" or "top". Fig.10 The back side of the paper is described as "inside" or "below". Fig.10 In FIG. 1 , the conductive pattern 3 located on the back side (lower side) of the sheet base 2 is indicated by oblique lines.
[0202] The conductive sheet 1 of the fourth configuration example is the same as the conductive sheet 1 of the third configuration example except that the configuration of the tip end portion of one conductive pattern 3 is different.
[0203] That is, in the conductive sheet 1 of the fourth configuration example, the tip portion 35a of one conductive pattern 3 is separated and independent. Therefore, since the tip portion 35a cannot be energized, no current is supplied from the tip portion 35a to the skin surface.
[0204] In this case, since no current flows through the frontalis and temporalis muscles, the occurrence of pain can be reduced.
[0205] <Fifth Configuration Example>
[0206] Next, a fifth configuration example of the conductive sheet 1 will be described.
[0207] Hereinafter, the conductive sheet 1 of the fifth configuration example will be described mainly with respect to the differences from the conductive sheets 1 of the first to fourth configuration examples described above, and descriptions of the same matters will be omitted.
[0208] Fig.11 It is a bottom view showing the conductive sheet 1 according to the fifth configuration example.
[0209] In the following instructions, Fig.11 The front side of the paper is described as "inside" or "below". Fig.11 The back side of the paper is described as the "surface" or "upper". Fig.11 The bioadhesive layer 4 is omitted.
[0210] The conductive sheet 1 of the fifth configuration example is the same as the conductive sheet 1 of the fourth configuration example except that it includes a shielding portion 5 provided so as to cover a portion of the sheet base 2 (conductive pattern 3 ).
[0211] The shielding portion 5 has at least one of a function of blocking the current supplied to the skin surface of the user and a function of reducing the stretchability of the conductive sheet 1 .
[0212] For example, Fig.11 As shown, the shielding portion 5 may be composed of an insulating sheet provided in a manner to cover the position of the conductive pattern 3 near the connection portion 34 on one side. According to such a structure, the current supplied to the skin surface from the vicinity of the connection portion 34 is blocked, and the current can be preferentially supplied to the skin surface from the side of the tip portion 35. In this way, by changing the position where the conductive pattern 3 is covered by the shielding portion 5, the position where the body sensation (muscle stimulation) is easily obtained can be adjusted.
[0213] In this case, the conductive sheet 1 can have a stretchable portion that is stretched and adhered to the skin surface and a non-stretchable portion that stably ensures the positional relationship between the skin surface and the conductive pattern 3 .
[0214] In this case, the stretchable portion can be a portion that needs to follow the shape of the face (for example, a portion corresponding to a skin surface prone to wrinkles, etc.). On the other hand, the non-stretchable portion can be a portion where muscle stimulation is desired to be applied effectively, etc.
[0215] <Sixth Configuration Example>
[0216] Next, a sixth configuration example of the conductive sheet 1 will be described.
[0217] Hereinafter, the conductive sheet 1 of the sixth configuration example will be described mainly with respect to the differences from the conductive sheets 1 of the first to fifth configuration examples described above, and descriptions of the same matters will be omitted.
[0218] Fig.12 (a) is a plan view showing a conductive sheet 1 according to a sixth configuration example. Fig.12 (b) is a side view showing the conductive sheet 1 of the sixth configuration example. Fig.13 yes Fig.12 Section view along line BB in A.
[0219] In the following instructions, Fig.12 The front side of the paper in (a) is described as the "surface" or "top". Fig.12 The back side of the paper in (a) is described as "inside" or "bottom". Fig.12 The upper side in (b) is described as "surface" or "upper", Fig.12 The lower side of (b) is described as "inside" or "lower". Fig.13 The upper side in the description is "table" or "upper", Fig.13 The lower side is described as "in" or "below". Fig.12 In FIG. 1 , the conductive pattern 3 and the like located on the back side (lower side) of the sheet base 2 are indicated by dotted lines.
[0220] like Fig.13 As shown, the sheet substrate 2 of the sixth configuration example includes a non-stretchable sheet substrate 201 and a stretchable sheet substrate 202, which are formed as one body. In addition, the sheet substrate 2 can also be formed by separately manufacturing the non-stretchable sheet substrate 201 and the stretchable sheet substrate 202, for example, by bonding with an adhesive, welding (thermal welding, high-frequency welding, ultrasonic welding), bonding components, etc. For example, in addition to the adhesive sheet 6 and the conductive tape 37, an additional adhesive tape can also be used as the adhesive component.
[0221] The non-stretchable sheet substrate 201 is preferably made of a harder material. There is no particular limitation on the material constituting the non-stretchable sheet substrate 201, and examples thereof include polyethylene terephthalate (PET), polyethylene naphthalate (PEN), polyimide (PI), polyphenylene sulfide (PPS), or fluororesin.
[0222] Furthermore, two through holes 2011 are formed in the non-stretchable sheet base material 201 .
[0223] A reinforcing block 24 is fixed to the upper surface of the non-stretchable sheet base 201 .
[0224] Two through holes 241 are formed in the reinforcing block 24, and are opened by the openings 222, respectively. Each through hole 241 communicates with each through hole 2011. In addition, two through holes 221 are formed at predetermined positions of the reinforcing block 24. The device body 10 is attached to the reinforcing block 24.
[0225] The reinforcing block 24 can be made of the same material as exemplified for the non-stretchable sheet base material 201 .
[0226] The stretchable sheet substrate 202 has high followability to the skin surface and can also respond to the movement of the skin, so it is excellent in supporting the conductive mode 3 as a skin electrode. The same materials as those listed in the sheet substrate 2 can be used as the constituent material of the stretchable sheet substrate 202.
[0227] Two conductive patterns 3 are provided on the lower surface of the stretchable sheet substrate 202. The conductive tape 37 is connected to the two conductive patterns 3 via electrical connection portions 38, respectively.
[0228] The conductive tape 37 may be formed of a resin tape in which conductive particles containing silver, gold, nickel, etc. are dispersed. In addition, a columnar connection portion 36 is fixed to the upper surface of each conductive tape 37. The connection portion 36 preferably has magnetism.
[0229] An adhesive tape 6 is provided between each conductive tape 37 and the sheet substrate 2. In addition, a through hole 61 is formed in the adhesive tape 6. As a constituent material of the adhesive tape 6, for example, an acrylic adhesive, a polyurethane adhesive, a silicone adhesive, a natural rubber adhesive, a synthetic rubber adhesive, etc. can be cited. These adhesives can be used alone or in combination of two or more.
[0230] In the assembled state of the conductive sheet 1 , the connection portion 36 is inserted into the through-hole 241 via the through-hole 61 and the through-hole 2011 .
[0231] The masking tape 7 is provided below the conductive tape 37. The masking tape 7 can be made of the same material as that exemplified for the non-stretchable sheet base material 201.
[0232] Furthermore, a bioadhesive layer 4 is provided at the bottom layer of the conductive sheet 1 .
[0233] According to such a structure, since the connection portion 36 of the terminal portion 11 electrically connected to the device body 10 is reinforced by the non-stretchable sheet substrate 201, the reinforcing block 24 and the masking tape 7, a stable connection between the conductive sheet 1 and the device body 10 can be achieved. In addition, it is easy to remove the device body 10 from the conductive sheet 1. On the other hand, since the conductive pattern 3 is supported by the stretchable sheet substrate 202, it can be attached to the skin surface with high followability.
[0234] The conductive sheet 1 of the second to sixth examples was applied to the eye area three times a week for 10 minutes a day. After four weeks of use, the thickness of the orbicularis oculi and temporalis muscles became thicker. After eight weeks of use, the moisture content and fundus ptosis were significantly improved.
[0235] Here, age-related changes in the eye area are prone to drooping above the eyes, sagging under the eyes, wrinkles around the eyes, etc. It is known that the cause of these age-related changes is not only due to physiological aging or photoaging caused by age, but also the influence of the muscles around the eyes in addition to the skin.
[0236] There are reports that the orbicularis oculi muscle, which forms a ring around the eye, becomes thinner with age, and it is well known that the youthful appearance is lost due to sagging around the eye, and the changes of age can be felt.
[0237] This time, it was found that by using a conductive sheet 1 that is easy to fit around the eyes, the muscles around the eyes can be electrically stimulated effectively, and the relaxation around the eyes can be significantly improved by exercising the orbicularis oculi muscle and the temporalis muscle.
[0238] Next, the conductive sheet of the present invention will be described.
[0239] The conductive sheet 1 is used to supply current to the skin surface of the user, and at least a part of it can be stretched in any direction, or at least a part of it has flexibility that can follow the skin surface. The conductive sheet 1 has a sheet substrate 2, a conductive pattern 3, and a bioadhesive layer 4. The conductive pattern 3 is arranged on the surface side of one side of the sheet substrate 2, and has a wiring portion 31 and an electrode portion 32 connected to one end of the wiring portion 31. The bioadhesive layer 4 is arranged on the side of the conductive pattern 3 opposite to the sheet substrate 2, and is configured to be attached to the skin surface of the user. In addition, the bioadhesive layer 4 is preferably in a gel state.
[0240] The configurations of the sheet substrate 2, the conductive pattern 3, and the bioadhesive layer 4 are respectively the same as those of the sheet substrate 2, the conductive pattern 3, and the bioadhesive layer 4 described in the skin treatment device of the present invention.
[0241] By using the conductive sheet 1, skin treatment can be performed on various areas of the skin surface according to the user's request.
[0242] In addition, the present invention can also be provided in the following various ways.
[0243] (1) A skin treatment device, characterized in that it comprises a conductive sheet at least part of which can be stretched in any direction, or a flexible conductive sheet at least part of which can follow the skin surface, and a device body installed on the conductive sheet and supplying current to the skin surface of the user; the conductive sheet comprises a sheet substrate, a conductive pattern and a bioadhesive layer, wherein the conductive pattern is arranged on the surface side of one side of the sheet substrate, and comprises a wiring portion and an electrode portion connected to one end side of the wiring portion, and the bioadhesive layer is arranged on the side of the conductive pattern opposite to the sheet substrate, and is configured to be adhered to the skin surface of the user.
[0244] (2) The skin treatment device according to (1) above, wherein the bioadhesive layer is in a gel state.
[0245] (3) The skin treatment device according to (1) or (2) above is characterized in that the electric current is at least one of an electric current for promoting the penetration of active ingredients contained in a skin external preparation, an electric current for imparting muscle stimulation, an electric current for warming the skin surface, and a microcurrent.
[0246] (4) The skin treatment device according to any one of (1) to (3) above, wherein the device body is detachably mounted on the conductive sheet.
[0247] (5) The skin treatment device according to any one of (1) to (4) above, wherein the device body is attached to the conductive sheet by magnetic force.
[0248] (6) The skin treatment device according to (4) or (5) above is characterized in that the device comprises a plurality of different types of the conductive sheets, and the device body is detachably mounted on each of the conductive sheets.
[0249] (7) The skin treatment device according to any one of (4) to (6) above, further comprising a positioning portion for the device body relative to the conductive sheet.
[0250] (8) A skin treatment device according to any one of (1) to (7) above, wherein the device body further includes a pair of terminal portions, and the wiring portion has a connection portion at the other end thereof that is connected to one of the terminal portions.
[0251] (9) The skin treatment device according to (8) above, wherein the sheet base has an opening that exposes the connection portion.
[0252] (10) The skin treatment device according to any one of (1) to (9) above, wherein the wiring portion and a portion of the electrode portion are arranged along an outer edge of the sheet base.
[0253] (11) A skin treatment device according to any one of (1) to (10) above, characterized in that the conductive sheet is in the shape of an elongated strip, and the device body is installed at the center or end of the conductive sheet in the longitudinal direction.
[0254] (12) A skin treatment device according to any one of (1) to (10) above, characterized in that the conductive sheet is in the shape of an elongated strip and is formed so that the width of one end thereof is greater than the width of the other end, and the device body is mounted on the one end of the conductive sheet.
[0255] (13) The skin treatment device according to (11) or (12) above, wherein the conductive sheet is bent midway in its longitudinal direction.
[0256] (14) The skin treatment device according to (13) above, wherein the conductive sheet is C-shaped or L-shaped.
[0257] (15) The skin treatment device according to any one of (1) to (14) above, wherein the area of the conductive sheet in a plan view is A [mm 2] , the area of the device body when viewed from above is set to B [mm 2 ], B / A is greater than 0.1 and less than 0.6.
[0258] (16) The skin treatment device according to any one of (1) to (15) above, wherein the bioadhesive layer is provided corresponding to a shape of the conductive pattern in a plan view.
[0259] (17) A skin treatment device according to any one of (1) to (16) above, wherein the electrical resistance of the conductive pattern and the bioadhesive layer as a whole, or the conductive pattern alone when not stretched, is 1000Ω or less.
[0260] (18) A skin treatment device according to any one of (1) to (17) above, characterized in that the conductive sheet also has a shielding portion arranged in a manner covering a portion of the sheet substrate, and the shielding portion has at least one of a function of blocking the current supplied to the skin surface of the user and a function of reducing the elasticity of the conductive sheet.
[0261] (19) A conductive sheet for supplying electric current to the skin surface of a user, and is a conductive sheet at least part of which can be stretched or retracted in any direction, or is a flexible conductive sheet at least part of which can follow the skin surface, characterized in that it comprises a sheet substrate, a conductive pattern and a bioadhesive layer, wherein the conductive pattern is arranged on the surface side of one side of the sheet substrate, and comprises a wiring portion and an electrode portion connected to one end side of the wiring portion, and the bioadhesive layer is arranged on the side of the conductive pattern opposite to the sheet substrate, and is configured to be adhered to the skin surface of the user.
[0262] (20) The conductive sheet according to (19) above, wherein the bioadhesive layer is in a gel state.
[0263] Of course, it's not limited to this.
[0264] As described above, although various embodiments related to the utility model have been described, these embodiments are presented as examples and are not intended to limit any scope of the utility model. The novel embodiment can be implemented in various other ways, and various omissions, substitutions and modifications can be made without departing from the scope of the subject matter of the utility model. The embodiment or its variation can be included in the scope or subject matter of the utility model, and can be included in the scope of the utility model described in the claims and its equivalent.
[0265] That is, the present invention is not limited to the above-mentioned embodiments, and can be implemented in an appropriate shape and an appropriate treatment method according to the wrinkles on the skin surface, the shape of the skin surface at the wearing position, the skin condition, and the effective ingredients used.
[0266] For example, a thin film heater may be disposed between the sheet substrate 2 and the bioadhesive layer 4. In this case, if a portion of the conductive pattern 3 is electrically connected to a portion of the thin film heater, current (power) may be supplied to the thin film heater. Thus, when the skin treatment device 100 is used, the thin film heater can exert a heating effect on the skin surface.
[0267] In addition, a magnetic layer may be disposed between the sheet substrate 2 and the bioadhesive layer 4. In this case, if a portion of the conductive pattern 3 is electrically connected to a portion of the magnetic layer, current (electricity) may be supplied to the magnetic layer. Thus, when the skin treatment device 100 is used, the magnetic force of the magnetic layer can be exerted to promote blood circulation on the skin surface. The magnetic layer may be produced by printing magnetic ink or pattern forming containing magnetic powder.
[0268] Furthermore, by using a conductive filler having magnetic properties, a conductive pattern 3 having magnetic properties can be formed.
[0269] The configurations of the conductive sheet 1 and the device body 10 are not limited to the above-described embodiments. For example, the device body 10 may be provided with a plurality of terminals (power contacts) 11 to supply current (power) from one device body 10 to a plurality of conductive sheets 1 .
[0270] Explanation of symbols
[0271] 100: Skin treatment device
[0272] 1: Conductive sheet
[0273] 2: Sheet substrate
[0274] 201: Non-stretchable sheet substrate
[0275] 2011: Through Holes
[0276] 202: Stretchable sheet substrate
[0277] 21: Wide section
[0278] 22: Narrow width
[0279] 221: Through hole
[0280] 222: Opening
[0281] 23: Ears
[0282] 24: Strengthening block
[0283] 241: Through hole
[0284] 3: Conductive mode
[0285] 3a: Slit
[0286] 31: Wiring section
[0287] 32: Electrode
[0288] 33: Convergence Department
[0289] 34: Connection
[0290] 35: Tip
[0291] 35a: Tip
[0292] 36: Connection
[0293] 37: Conductive tape
[0294] 38: Electrical connection
[0295] 4: Bioadhesive layer
[0296] 4a: Slit
[0297] 5: Shielding
[0298] 6: Adhesive tape
[0299] 61: Through hole
[0300] 7: Masking tape
[0301] 10: Device body
[0302] 101: Pin
[0303] 11: Terminal
[0304] 12: Operation button
[0305] 13: Power supply
[0306] 14: Control Department
[0307] 15: Circuit Department
Claims
1. A skin treatment device, characterized in that: A conductive sheet at least part of which can be stretched in any direction, or a conductive sheet at least part of which is flexible and can follow the skin surface, and a device body mounted on the conductive sheet and supplying current to the skin surface of the user; The conductive sheet comprises a sheet substrate, a conductive pattern and a bioadhesive layer, wherein: The conductive pattern is provided on one surface side of the sheet substrate and includes a wiring portion and an electrode portion connected to one end side of the wiring portion. The bioadhesive layer is disposed on the side of the conductive pattern opposite to the sheet substrate and is configured to be adhered to the skin surface of the user.
2. The skin treatment device according to claim 1, characterized in that The bioadhesive layer is in gel form.
3. The skin treatment device according to claim 1 or 2, characterized in that: The electric current is at least one of an electric current for promoting penetration of an active ingredient contained in a skin external preparation, an electric current for imparting muscle stimulation, an electric current for warming the skin surface, and a microcurrent.
4. The skin treatment device according to claim 1 or 2, characterized in that: The device main body is detachably mounted on the conductive sheet.
5. The skin treatment device according to claim 1 or 2, characterized in that: The device body is mounted on the conductive sheet by magnetic force.
6. The skin treatment device according to claim 4, characterized in that: There are multiple types of conductive sheets, The device main body is detachably mounted on each of the conductive sheets.
7. The skin treatment device according to claim 4, characterized in that: A portion for positioning the device body relative to the conductive sheet is further provided.
8. The skin treatment device according to claim 1 or 2, characterized in that: The device body further includes a pair of terminal portions, The wiring portion has a connection portion connected to one of the terminal portions at the other end side.
9. The skin treatment device according to claim 8, characterized in that: The sheet base has an opening that exposes the connection portion.
10. The skin treatment device according to claim 1 or 2, characterized in that: The wiring portion and a part of the electrode portion are arranged along an outer edge of the sheet base.
11. The skin treatment device according to claim 1 or 2, characterized in that: The conductive sheet is in the shape of a long strip. The device body is mounted at a central portion or an end portion in a longitudinal direction of the conductive sheet.
12. The skin treatment device according to claim 1 or 2, characterized in that: The conductive sheet is in the shape of an elongated strip, and is formed such that the width of one end thereof is greater than the width of the other end thereof. The device body is mounted on the one end side of the conductive sheet.
13. The skin treatment device according to claim 11, characterized in that: The conductive sheet is bent midway in its length direction.
14. The skin treatment device according to claim 13, characterized in that: The conductive sheet is in a C shape or an L shape.
15. The skin treatment device according to claim 1 or 2, characterized in that: The area of the conductive sheet in a plan view is set to A [mm 2 ], the area of the device body when viewed from above is set to B [mm 2 ], B / A is greater than 0.1 and less than 0.
6.
16. The skin treatment device according to claim 1 or 2, characterized in that: The bioadhesive layer is disposed corresponding to a shape of the conductive pattern in a plan view.
17. The skin treatment device according to claim 1 or 2, characterized in that: The electrical resistance of the conductive pattern and the bioadhesive layer as a whole, or the conductive pattern alone, when not stretched is 1000Ω or less.
18. The skin treatment device according to claim 1 or 2, characterized in that: The conductive sheet further includes a shielding portion provided to cover a portion of the sheet substrate. The shielding portion has at least one of a function of blocking the current supplied to the skin surface of the user and a function of reducing the stretchability of the conductive sheet.
19. A conductive sheet for supplying current to the skin surface of a user, wherein at least a portion of the conductive sheet can be stretched in any direction, or at least a portion of the conductive sheet is flexible and can follow the skin surface, characterized in that: It has a sheet substrate, a conductive pattern and a bioadhesive layer, wherein: The conductive pattern is provided on one surface side of the sheet substrate and includes a wiring portion and an electrode portion connected to one end side of the wiring portion. The bioadhesive layer is disposed on the side of the conductive pattern opposite to the sheet substrate and is configured to be adhered to the skin surface of the user.
20. The conductive sheet according to claim 19, characterized in that: The bioadhesive layer is in gel form.
